While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Kennedy has criticized the popular Novo Nordisk NOVOb.CO drug Ozempic, which is often prescribed for weight loss, saying it ...

Fear is spreading across healthcare stocks after news emerged that President-elect Donald Trump will nominate vaccine skeptic ...

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

Pharma and biotech stocks are down due to concerns over Robert F. Kennedy Jr. possibly taking the helm at HHS. Read more here ...

Donald Trump’s nomination of vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services is sending shockwaves throughout the broader pharma industry, beyond [vaccine ...

With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...